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Abstract
Background: Gammaherpesviruses (GHVs) are a large group of dsDNA viruses that can infect humans and several
animal species. The two human GHVs, Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus are known
for their oncogenic properties in individuals with immunodeficiency. Recently, the first feline GHV, Felis catus
gammaherpesvirus 1 (FcaGHV1) was discovered and frequently found in domestic cats in Australia, Singapore and
the USA. FcaGHV1 is more likely to be detected in cats co-infected with the feline immunodeficiency virus (FIV).
Findings: The prevalence of FcaGHV1 in pet cats from Germany and Austria was 16.2 % (95 % CI = 12.38-20.02). The
odds for GHV infection were greater for FIV positive (OR = 4.5), male (OR = 13.32) and older (OR = 2.36) cats. Furthermore,
FcaGHV1 viral loads were significantly higher in FIV-infected cats compared to matched controls.
Conclusions: GHV infections are common in domestic cats in Central Europe. The worldwide distribution of FcaGHV1
can be assumed. A potential role as a co-factor in FIV-induced pathogeneses is supported.
Background
Gammaherpesviruses (GHVs) are a large and widely
distributed group of double-stranded DNA viruses within
the Herpesviridae family [1]. The two human GHVs,
Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated
herpesvirus (KSHV) are of particular importance due to
their association with the development of cancer in im-
munosuppressed HIV patients [2]. In 2014, the first GHVs
native to feline species (domestic cats, bobcats and pumas)
were discovered in the USA [3]. Felis catus gammaher-
pesvirus 1 (FcaGHV1) was then frequently detected in
domestic cats in Australia, Singapore and the USA [3, 4].
Interestingly, the prevalence of FcaGHV1 is higher in cats
co-infected with the feline immunodeficiency virus (FIV)
[4]. This feline retrovirus is a widespread pathogen in cats
causing an AIDS-like immunodeficiency syndrome [5].
Furthermore, FIV-infected animals have a higher risk for
the development of lymphoid malignancies, especially
lymphomas [6]. However, the underlying mechanisms of
FIV associated malignancies are not completely understood.
Thus, similar to the human GHVs, FcaGHV1 in cats might
be a co-factor for malignant transformation in immuno-
compromised individuals [7]. In this report, we assess the
prevalence of FcaGHV1 among client-owned pet cats in
Germany and Austria and evaluate potential risk factors
such as FIV co-infection.
Results
A total of 462 cats from Germany (n = 402) and Austria
(n = 60) were tested for the presence of FcaGHV1 DNA
by quantitative PCR (qPCR) and FIV provirus DNA
(qPCR and conventional PCR). The prevalence of
FcaGHV1 was 16.2 % (95 % CI = 12.38-20.02) in FIV
negative cats from both countries (n = 358). Among
FIV-infected cats (all from Germany, n = 104) a co-
infection with FcaGHV1 could be detected in 40.4 %
(95 % CI = 30.95-49.81) of the animals. All tested Austrian
cats were FIV negative and therefore excluded from the
risk factor analysis. Odds ratios (OR) were calculated to
evaluate risk factors for FcaGHV1 infection. FIV-infected
cats in Germany showed a significantly higher probability
for being FcaGHV1 positive (OR = 4.5) compared to
non-infected animals (Table 1). Other factors that
could be associated with FcaGHV1 infection were being
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male (OR = 13.32) and an increasing age (OR = 2.36).
No association could be detected for the neuter status
of the cats. Detailed clinical data were only available for
the cats from Austria. These were grouped according
to their health status (healthy vs. chronically ill). How-
ever, no significant differences could be found between
the two groups. The numbers of FcaGHV1 and FIV
DNA copies in the cat blood were measured by qPCR
and analyzed for the individual groups. The FcaGHV1
viral loads were significantly (p = 0.0018) higher in
FIV-infected cats (median FcaGHV1 viral load: 529
copies/106 cells) compared to non-infected cats (221
copies/106 cells; Fig. 1). Both groups have been matched
for age and sex. FcaGHV1 copy numbers, however, did
not correlate with the numbers of FIV copies in the co-
infected animals (Spearman r = −0.024; Additional file 1).
Parts of the FcaGHV1 glycoprotein B (gB) gene were
sequenced from 12 German and 6 Austrian virus isolates.
The gB sequences of all German and 5 Austrian samples
(GenBank: KP862648, KP862649) were identical to those
of previously reported strains from Australia and the USA
[3, 4]. In one Austrian isolate (KT241042), a single, syn-
onymous nucleotide polymorphism (adenine to guanine)
was detected at nucleotide position 249 of the partial US
gB sequence (KF840715) published by Troyer et al. [3].
Discussion
All samples analyzed in this study have been taken from
pet cats during a veterinary medical examination. Clinical
data were only available for a part of the animals. On
account of this, only prevalence rates and already known
risk factors for FcaGHV1 infection were evaluated [4].
The prevalence of FcaGHV1 among FIV negative cats in
Germany and Austria (16.2 %) is similar to previously
reported data from Australia (11.4 %), Singapore (9.6 %)
and the USA (19.1 %) [4]. In comparison, FIV-infected
animals from Germany were 4 times more likely to be
tested FcaGHV1 positive. Furthermore, virus DNA loads
were significantly higher in the FIV positive group. These
results are congruent with previous reports [4]. Taken
together, these findings indicate possible pathogenic inter-
actions between FcaGHV1 and FIV, similar to the known
associations of the human herpesviruses EBV and KSHV
Table 1 Prevalence and risk factors of FcaGHV1 infection in domestic cats in Germany and Austria; based on the results of chi square
tests and the calculation of odds ratios
Factor Category Prevalence FcaGHV1 P value Odds ratio 95 % CI Origin
FIV status Negative 39/298 (13.1 %) Ref - - Germany
Positive 42/104 (40.4 %) <0.0001* 4.499 2.684 – 7.541 Germany
Sex Female 10/123 (8.1 %) Ref - - Germany
Male 99/183 (54.1 %) <0.0001* 13.320 6.553 – 27.07 Germany
Age ≤5 years 19/152 (12.5 %) Ref - - Germany
>5.5 years 31/123 (25.2 %) 0.0066* 2.359 1.256 – 4.429 Germany
Neuter status Male intact 17/63 (27 %) Ref - - Germany
Male neutered 36/120 (30 %) 0.6691 1.160 0.588 – 2.289 Germany
Female intact 3/55 (5.5 %) Ref - - Germany
Female neutered 7/68 (10.3 %) 0.3288 1.989 0.489 – 8.087 Germany
Health status Healthy1 8/31 (25.8 %) Ref - - Austria
Chronically ill2 11/29 (37.9 %) 0.3130 1.757 0.585 – 5.279 Austria
CI = confidence interval, Ref = Reference category, * = statistically significant (p < 0.05), 1Includes cats examined for injury, intoxication or routine checkup, 2Cats
diagnosed with chronic condition: cardiovascular disease (n = 6), tumor (n = 14), chronic kidney disease (n = 5), chronic inflammation (n = 3), neurological disorder
(n = 1). Only animals with the relative information are enlisted
Fig. 1 FcaGHV1 DNA viral loads are significantly higher in the blood of
cats co-infected with FIV. Data obtained from FIV positive cats (n = 39),
matched for age and sex to the FIV negative control group (n = 39)
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with HIV [2, 8]. In HIV patients, the virus-induced im-
munosuppression is presumed to generate an environment
that facilitates the oncogenic properties of the GHVs. Thus,
virally transformed cells cannot be properly eliminated by
the immune system which eventually results in cell prolifer-
ation and the development of malignancies [8]. In this
context, the increased FcaGHV1 viral loads in co-infected
cats might be also a result of the FIV-induced immunosup-
pression, which possibly enables the reactivation of latent
herpesviruses and subsequently enhances the replication of
the co-pathogen. Other risk factors that were detected in
the present study were related to the cats’ demographics.
Male and older cats are more likely to be FcaGHV1 posi-
tive. These factors have been also described to increase the
chance of FIV infection [9, 10]. No significant differences
were detected between intact and neutered cats of the same
sex. With regard to FIV, several studies reported a de-
creased risk of infection for neutered cats, while others
found no significant effect of the neuter status [11–13].
When comparing healthy and diseased cats from Austria,
we observed slightly greater numbers of virus-positive cats
in the diseased group. Though, the statistical associations
were not significant. In general, the determination whether
a virus infection contributes to an animal’s disease status
can be challenging in many cases. With the exception of
lymphoid malignancies, clinical abnormalities found in
FIV-infected cats are generally not significantly different to
those of uninfected animals [10]. Additional studies with
higher numbers of cats representing better defined disease
categories are necessary to further investigate the patho-
genic potential of FcaGHV1. Overall, striking similarities
for the risk factors of the two viruses can be noted, indica-
ting that both viruses share common transmission routes
[4]. FcaGHV1 gB sequence comparisons of 12 German and
6 Austrian isolates with previously reported strains could
detect one new nucleotide variation for this gene, found in
a single isolate from Austria. As viruses with large dsDNA
genomes are generally expected to have rather low muta-
tion rates [14] and especially the FcaGHV1 gB gene is
known to be highly conserved [3, 4], longer genome
sequences will be needed to get deeper insights into the
molecular relationship between different virus isolates.
In summary, our results show that GHV infections are
common among European pet cats. Together with previ-
ous observations, this indicates that FcaGHV1 is most
likely present in cat populations worldwide. FcaGHV1
detection was associated with male sex, increasing age
and positive FIV status. Increased viral loads in co-
infected animals support the assumption of pathogenic
interactions between feline GHVs and FIV.
Methods
EDTA blood samples were collected from pet cats
presented to veterinarians in Germany and Austria in
2012–2015. All samples were taken as a part of the rou-
tine clinical examination. DNA was isolated from whole
blood using commercial kits. FcaGHV1 qPCR and primers
for DNA sequencing of the viral gB gene have been de-
scribed [3, 4]. Bi-directional Sanger sequencing was
performed by Microsynth, Balgach, Switzerland. The
number of cell equivalents for each DNA sample was
determined based on qPCR quantification of the feline
RPP30 gene [15]. RPP30 copy numbers were used for the
calculation of viral loads and as a control for the DNA
preparation. The observed host gene numbers in the DNA
samples ranged from 1.17 × 104 - 1.72 × 105 copies RPP30/
2 μl, which was found to be sufficient to reproducibly
detect also low levels of viral DNA. The detection limit of
the virus-specific qPCR assay, which was evaluated by a
dilution series of FcaGHV1 gB-containing plasmid DNA,
was 2 copies per reaction. All cats were tested for FIV pro-
virus DNA by qPCR and conventional PCR as previously
described [16, 17]. Plasmid DNA standards were prepared
for all qPCR assays (FcaGHV1, FIV1416p and RPP30) to
quantitate the DNA copy numbers. Statistical analyses
were performed using the GraphPad Prism 5 software
(GraphPad Software, Inc.). A chi-square goodness of fit
test and odds ratios were used to compare prevalence
rates between the groups. FcaGHV1 viral loads were
compared using a two-sided Mann Whitney U test.
Spearman’s rank correlation coefficient was calculated
to assess the relationship between FcaGHV1 and FIV
viral loads. Statistical associations were considered
significant at p < 0.05.
Additional file
Additional file 1: No correlation of FcaGHV1 and FIV DNA copy
numbers in the blood of co-infected cats. Virus copy and cell numbers
were measured by quantitative PCR. Spearman’s rank correlation coefficient
was calculated to assess the statistical association. (TIFF 10392 kb)
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